サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：血液培養検査の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年までの予測
市場調査レポート
商品コード
1319891

血液培養検査の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年までの予測

Global Blood Culture Test Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 230 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
血液培養検査の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年までの予測
出版日: 2023年07月01日
発行: Value Market Research
ページ情報: 英文 230 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血液培養検査市場の世界需要は、調査期間2023年～2030年のCAGR 9.1%で、2022年の55億4,000万米ドルから、2030年にはほぼ111億3,000万米ドルの市場規模に達すると推定されます。

血液培養検査は、患者の血流中の細菌、真菌、その他の微生物（病原体）の存在を検出するために使用される医療診断手順です。この検査は、重症で生命を脅かす可能性のある血流感染症や敗血症の診断に極めて重要です。

市場力学：

効果的な治療にはタイムリーで正確な診断が不可欠であるため、世界中で敗血症や血流感染症の発生率が増加していることが重要な促進要因となっています。医療施設が感染対策に重点を置くようになっていることも、感染を早期に特定して適切な対策を実施するための血液培養検査の需要に寄与しています。自動化システムや連続モニタリングなど、血液培養技術の技術的進歩により、病原菌検出の感度とスピードが向上し、患者の転帰が改善されています。さらに、免疫機能が低下した患者の増加や、抗菌薬耐性と闘うための抗菌薬スチュワードシップの重要性が、市場の成長を後押ししています。さらに、発展途上国における医療支出やインフラ整備の増加、早期感染診断の重要性を強調する新興諸国のパンデミックの影響も、血液培養検査の需要に寄与しています。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは血液培養検査の世界市場における各セグメントを包括的に評価することもできます。血液培養検査業界の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析：

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける血液培養検査市場の現在および将来の需要を強調する地域展望をカバーしています。さらに、著名な全地域における個々のアプリケーションセグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 血液培養検査-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 血液培養検査の世界市場分析：方法別

  • 方法別概要
  • 実績データと予測データ
  • 方法別分析
  • 従来型/手動
  • 自動化

第6章 血液培養検査の世界市場分析：製品別

  • 製品別概要
  • 実績データと予測データ
  • 製品別分析
  • 消耗品（血液培養培地、アッセイキット・試薬、血液培養アクセサリー）
  • 機器（自動血液培養システム、支援検査機器）
  • ソフトウェア・サービス

第7章 血液培養検査の世界市場分析：技術別

  • 技術別概要
  • 実績データと予測データ
  • 技術別分析
  • 培養ベース技術
  • 分子技術
  • マイクロアレイ
  • PCR（ポリメラーゼ連鎖反応）
  • PNA-FISH（ペプチド核酸-蛍光in situハイブリダイゼーション）
  • プロテオミクス技術

第8章 血液培養検査の世界市場分析：用途別

  • 用途別概要
  • 実績データと予測データ
  • 用途別分析
  • 菌血症
  • 真菌症
  • マイコバクテリア検出

第9章 血液培養検査の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • 実績データと予測データ
  • エンドユーザー別分析
  • 病院検査室
  • リファレンス研究所
  • 学術研究機関
  • その他の研究所

第10章 血液培養検査の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第11章 血液培養検査企業の競合情勢

  • 血液培養検査市場の競合
  • 提携／協力／合意
  • 合併・買収
  • 新製品の発売
  • その他の開発

第12章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Becton
  • Dickinson and Company（US）
  • bioMerieux SA（France）
  • Thermo Fisher Scientific Inc.（US）
  • Luminex Corporation（US）
  • Danaher Corporation（US）
  • Bruker Corporation（US）
  • IRIDICA（a subsidiary of Abbott Laboratories）（US）
  • Roche Diagnostics（Switzerland）
  • T2 Biosystems Inc.（US）
  • Anaerobe Systems Inc.（US）
  • OpGen Inc.（US）
  • Meditech Technologies India Private Limited（India）
  • Carl Zeiss AG（Germany）
  • Nikon Corporation（Japan）
  • BINDER GmbH（Germany）
  • Biobase Biotech（Jinan）Co. Ltd.（China）

注-企業プロファイルにおいて、財務の詳細や最近の動向は、入手可能な情報に基づいているか、非公開会社の場合はカバーしていない可能性があります。

図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis by Method (USD MN)
  • Conventional/Manual Methods Market Sales by Geography (USD MN)
  • Automated Methods Market Sales by Geography (USD MN)
  • Analysis Market by Product (USD MN)
  • Consumables (Blood Culture Media, Assay Kits & Reagents, Blood Culture Accessories) Market Sales by Geography (USD MN)
  • Instruments (Automated Blood Culture Systems, Supporting Laboratory Equipment) Market Sales by Geography (USD MN)
  • Software And Services Market Sales by Geography (USD MN)
  • Analysis by Technology (USD MN)
  • Culture-Based Technology Market Sales by Geography (USD MN)
  • Molecular Technologies Market Sales by Geography (USD MN)
  • Microarrays Market Sales by Geography (USD MN)
  • PCR (Polymerase Chain Reaction) Market Sales by Geography (USD MN)
  • PNA-FISH (Peptide Nucleic Acid - Fluroscent in Situ Hybridization) Market Sales by Geography (USD MN)
  • Proteomics Technology Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Bacteremia Market Sales by Geography (USD MN)
  • Fungemia Market Sales by Geography (USD MN)
  • Mycobacterial Detection Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Hospital Laboratories Market Sales by Geography (USD MN)
  • Reference Laboratories Market Sales by Geography (USD MN)
  • Academic Research Laboratories Market Sales by Geography (USD MN)
  • Other Laboratories Market Sales by Geography (USD MN)
  • Global Blood Culture Test Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Blood Culture Test Report
  • Market Research Process
  • Market Research Methodology
  • Global Blood Culture Test Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Method
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Method (USD MN)
  • Conventional/Manual Methods Market Sales by Geography (USD MN)
  • Automated Methods Market Sales by Geography (USD MN)
  • Global Market Analysis by Product (USD MN)
  • Consumables (Blood Culture Media, Assay Kits & Reagents, Blood Culture Accessories) Market Sales by Geography (USD MN)
  • Instruments (Automated Blood Culture Systems, Supporting Laboratory Equipment) Market Sales by Geography (USD MN)
  • Software And Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Culture-Based Technology Market Sales by Geography (USD MN)
  • Molecular Technologies Market Sales by Geography (USD MN)
  • Microarrays Market Sales by Geography (USD MN)
  • PCR (Polymerase Chain Reaction) Market Sales by Geography (USD MN)
  • PNA-FISH (Peptide Nucleic Acid - Fluroscent in Situ Hybridization) Market Sales by Geography (USD MN)
  • Proteomics Technology Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Bacteremia Market Sales by Geography (USD MN)
  • Fungemia Market Sales by Geography (USD MN)
  • Mycobacterial Detection Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospital Laboratories Market Sales by Geography (USD MN)
  • Reference Laboratories Market Sales by Geography (USD MN)
  • Academic Research Laboratories Market Sales by Geography (USD MN)
  • Other Laboratories Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112111745

The global demand for Blood Culture Test Market is presumed to reach the market size of nearly USD 11.13 BN by 2030 from USD 5.54 BN in 2022 with a CAGR of 9.1% under the study period 2023 - 2030.

A blood culture test is a medical diagnostic procedure which is used to detect the presence of bacteria, fungi, or other microorganisms (pathogens) in a patient's bloodstream. The test is crucial in diagnosing bloodstream infections or sepsis, a severe and potentially life-threatening condition.

MARKET DYNAMICS:

The growing incidence of sepsis and bloodstream infections worldwide is a significant driver, as timely and accurate diagnosis is crucial for effective treatment. Healthcare facilities' increasing focus on infection control measures also contributes to the demand for blood culture tests to identify infections early and implement appropriate measures. Technological advancements in blood culture technology, including automated systems and continuous monitoring, have improved the sensitivity and speed of pathogen detection, enhancing patient outcomes. Additionally, the rising number of patients with compromised immune systems and the importance of antimicrobial stewardship to combat antimicrobial resistance fuel the market's growth. Furthermore, increasing healthcare spending and infrastructure development in developing countries and the impact of the COVID-19 pandemic, which emphasizes the importance of early infection diagnosis, also contribute to the demand for blood culture tests.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of blood culture test. The growth and trends of blood culture test industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the blood culture test market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Method

  • Conventional/Manual Methods
  • Automated Methods

By Product

  • Consumables (Blood Culture Media, Assay Kits & Reagents, Blood Culture Accessories)
  • Instruments (Automated Blood Culture Systems, Supporting Laboratory Equipment)
  • Software And Services

By Technology

  • Culture-Based Technology
  • Molecular Technologies
  • Microarrays
  • Pcr (Polymerase Chain Reaction)
  • Pna-Fish (Peptide Nucleic Acid - Fluroscent In Situ Hybridization)
  • Proteomics Technology

By Application

  • Bacteremia
  • Fungemia
  • Mycobacterial Detection

By End User

  • Hospital Laboratories
  • Reference Laboratories
  • Academic Research Laboratories
  • Other Laboratories

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Blood Culture Test market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Blood Culture Test market include Becton, Dickinson and Company (US), bioMerieux SA (France), and Thermo Fisher Scientific Inc. (US), Luminex Corporation (US), Danaher Corporation (US), Bruker Corporation (US), IRIDICA (a subsidiary of Abbott Laboratories) (US), Roche Diagnostics (Switzerland), T2 Biosystems, Inc. (US), Anaerobe Systems, Inc. (US), OpGen, Inc. (US), Meditech Technologies India Private Limited (India), Carl Zeiss AG (Germany), Nikon Corporation (Japan), BINDER GmbH (Germany), Biobase Biotech (Jinan) Co. Ltd. (China). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . BLOOD CULTURE TEST - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Method
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Technology
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By End User
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BLOOD CULTURE TEST MARKET ANALYSIS BY METHOD

  • 5.1 Overview by Method
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Method
  • 5.4 Conventional/Manual Methods Historic and Forecast Sales by Regions
  • 5.5 Automated Methods Historic and Forecast Sales by Regions

6 . GLOBAL BLOOD CULTURE TEST MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Consumables (Blood Culture Media, Assay Kits & Reagents, Blood Culture Accessories) Historic and Forecast Sales by Regions
  • 6.5 Instruments (Automated Blood Culture Systems, Supporting Laboratory Equipment) Historic and Forecast Sales by Regions
  • 6.6 Software And Services Historic and Forecast Sales by Regions

7 . GLOBAL BLOOD CULTURE TEST MARKET ANALYSIS BY TECHNOLOGY

  • 7.1 Overview by Technology
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Technology
  • 7.4 Culture-Based Technology Historic and Forecast Sales by Regions
  • 7.5 Molecular Technologies Historic and Forecast Sales by Regions
  • 7.6 Microarrays Historic and Forecast Sales by Regions
  • 7.7 PCR (Polymerase Chain Reaction) Historic and Forecast Sales by Regions
  • 7.8 PNA-FISH (Peptide Nucleic Acid - Fluroscent in Situ Hybridization) Historic and Forecast Sales by Regions
  • 7.9 Proteomics Technology Historic and Forecast Sales by Regions

8 . GLOBAL BLOOD CULTURE TEST MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Bacteremia Historic and Forecast Sales by Regions
  • 8.5 Fungemia Historic and Forecast Sales by Regions
  • 8.6 Mycobacterial Detection Historic and Forecast Sales by Regions

9 . GLOBAL BLOOD CULTURE TEST MARKET ANALYSIS BY END USER

  • 9.1 Overview by End User
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End User
  • 9.4 Hospital Laboratories Historic and Forecast Sales by Regions
  • 9.5 Reference Laboratories Historic and Forecast Sales by Regions
  • 9.6 Academic Research Laboratories Historic and Forecast Sales by Regions
  • 9.7 Other Laboratories Historic and Forecast Sales by Regions

10 . GLOBAL BLOOD CULTURE TEST MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. South East Asia Sales Analysis
    • 10.5.10. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE BLOOD CULTURE TEST COMPANIES

  • 11.1. Blood Culture Test Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF BLOOD CULTURE TEST INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Becton
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Dickinson and Company (US)
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. bioMerieux SA (France)
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Thermo Fisher Scientific Inc. (US)
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Luminex Corporation (US)
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Danaher Corporation (US)
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Bruker Corporation (US)
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. IRIDICA (a subsidiary of Abbott Laboratories) (US)
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. Roche Diagnostics (Switzerland)
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. T2 Biosystems Inc. (US)
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Anaerobe Systems Inc. (US)
    • 12.13.1. Company Overview
    • 12.13.2. Company Revenue
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. OpGen Inc. (US)
    • 12.14.1. Company Overview
    • 12.14.2. Company Revenue
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. Meditech Technologies India Private Limited (India)
    • 12.15.1. Company Overview
    • 12.15.2. Company Revenue
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. Carl Zeiss AG (Germany)
    • 12.16.1. Company Overview
    • 12.16.2. Company Revenue
    • 12.16.3. Products
    • 12.16.4. Recent Developments
  • 12.17. Nikon Corporation (Japan)
    • 12.17.1. Company Overview
    • 12.17.2. Company Revenue
    • 12.17.3. Products
    • 12.17.4. Recent Developments
  • 12.18. BINDER GmbH (Germany)
    • 12.18.1. Company Overview
    • 12.18.2. Company Revenue
    • 12.18.3. Products
    • 12.18.4. Recent Developments
  • 12.19. Biobase Biotech (Jinan) Co. Ltd. (China)
    • 12.19.1. Company Overview
    • 12.19.2. Company Revenue
    • 12.19.3. Products
    • 12.19.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies